|
HIV dementia
Citations 1-10 of 47 total displayed.
|
Most recent content
(11 Nov 2009):
|
- ARTICLES
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease
- D. B. Clifford, A. M. Fagan, D. M. Holtzman, J. C. Morris, M. Teshome, A. R. Shah, and J. S. K. Kauwe
Neurology first published on November 11, 2009 as doi: WNL.0b013e3181c5b445.
[Abstract]
Rapid PDF
- EDITORIALS
CSF biomarkers in HIV dementia. Through a glass darkly
- Dawn McGuire
Neurology first published on November 11, 2009 as doi: WNL.0b013e3181c51a92.
Rapid PDF
|
Past content
(since Jan 2001):
|
- ARTICLES
Selegiline and oxidative stress in HIV-associated cognitive impairment
- G. Schifitto, C. T. Yiannoutsos, T. Ernst, B. A. Navia, A. Nath, N. Sacktor, C. Anderson, C. M. Marra, D. B. Clifford For the ACTG 5114 Team
Neurology first published on November 4, 2009 as doi: WNL.0b013e3181c51a48.
[Abstract]
Rapid PDF
- ARTICLES
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men
- J. T. Becker, L. Kingsley, J. Mullen, B. Cohen, E. Martin, E. N. Miller, A. Ragin, N. Sacktor, O. A. Selnes, B. R. Visscher For the Multicenter AIDS Cohort Study
Neurology 2009; 73: 1292-1299.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Resting cerebral blood flow: A potential biomarker of the effects of HIV in the brain
- B. M. Ances, D. Sisti, F. Vaida, C. L. Liang, O. Leontiev, J. E. Perthen, R. B. Buxton, D. Benson, D. M. Smith, S. J. Little, D. D. Richman, D. J. Moore, R. J. Ellis On behalf of the HNRC group
Neurology 2009; 73: 702-708.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
- L. A. Cysique, F. Vaida, S. Letendre, S. Gibson, M. Cherner, S. P. Woods, J. A. McCutchan, R. K. Heaton, and R. J. Ellis
Neurology 2009; 73: 342-348.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
HIV-associated brain dysfunction in the era of HAART. Reasons for hope, but continued concern
- Ronald A. Cohen and Assawin Gongvatana
Neurology first published on June 24, 2009 as doi: WNL.0b013e3181b1220d.
Rapid PDF
- ARTICLES
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
- N. Sacktor, N. Nakasujja, R. L. Skolasky, K. Robertson, S. Musisi, A. Ronald, E. Katabira, and D. B. Clifford
Neurology 2009; 72: 165-170.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region
- E. Wright, B. Brew, A. Arayawichanont, K. Robertson, K. Samintharapanya, S. Kongsaengdao, M. Lim, S. Vonthanak, L. Lal, C. Sarim, S. Huffam, P. Li, D. Imran, J. Lewis, W. H. Lun, A. Kamarulzaman, G. Tau, S. T. Ali, K. Kishore, M. P. Bain, R. Dwyer, G. McCormack, M. Hellard, C. Cherry, J. McArthur, and S. Wesselingh
Neurology 2008; 71: 50-56.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Preserved cognitive functioning over time in asymptomatic HIV-infected people in the MACS cohort
- Ronald A. Cohen and Bradford A. Navia
Neurology 2007; 69: 2195-2196.
[Full text]
[PDF]
|
|
